medigraphic.com
ISSN 1561-3011 (Electronic)

2021, Number 2

<< Back Next >>

Rev Cubana Invest Bioméd 2021; 40 (2)

Kidney damage in COVID-19 patients

González-Milán ZC, Alarcón-González R, Escalona-González SO

Language: Spanish
References: 27
Page: 1-10
PDF size: 223.21 Kb.


ABSTRACT

Introduction: COVID-19 is a relatively new disease that affects various organs. Associated as it is to mortality, kidney damage should be identified as early as possible.
Objective: Conduct a bibliographic review aimed at describing kidney damage in COVID-19 patients.
Methods: A bibliographic review was conducted of materials about the topic published from 20 April to 25 August 2020. The search was carried out in the databases PubMed, SciELO, Ebsco and Clinical Key, as well as the search engine Google Scholar. Analytic-synthetic, inductive-deductive and historical-logical methods were used.
Data analysis and integration: In order to obtain an early diagnosis allowing to modify the prognosis and natural evolution of mortality, a large number of studies are performed on patients carrying COVID-19. Papers are found in the scientific literature which refer to the importance of detecting kidney damage. It has been found that kidney damage, either developing before or during the course of the disease, plays an important role in the increase in lethality.
Conclusions: Kidney damage is common in COVID-19 patients. Describing the mechanisms causing the kidney injury is a fundamental pillar to establish the prognosis for these patients. The description of kidney damage during COVID-19 is still scarce in the scientific literature.


REFERENCES

  1. Reina J. El SARS-CoV-2, una nueva zoonosis pandémica que amenaza al mundo. Vacunas. 2020;21(1):17-22. DOI: 10.1016/j.vacun.2020.03.001

  2. Zhao G. Tomar medidas preventivas inmediatamente: evidencia de China sobre el COVID-19. Gac Sanit. 2020;34(3):217-219. DOI: 10.1016/j.gaceta.2020.03.002

  3. Ribas-Freitas AR, Napimoga M, Donalisio M. Análise da gravidade da pandemia de Covid-19. Epidemiol. Serv. Saude, Brasília. 2020;29(2):e2020119. DOI: 10.5123/s1679-49742020000200008

  4. Caruso-Chate R, Nunes-Fonseca KU, DuartePassos RB, da Silva-Teles GB. Apresentação tomográfica da infecção pulmonar na COVID-19: experiencia brasileira inicial. J Bras Pneumol. 2020;46(2). DOI: 10.36416/1806-3756/e20200121

  5. Gedney N. Long-Term Hemodialysis during the COVID-19 Pandemic. Am Soc of Nephrol. 2020;15(8):1073-1074. DOI: 10.2215/CJN.09100620

  6. Ahmed W, Al O, Joseph A. Outcomes of patients with end stage kidney disease on dialysis with COVID-19 in Abu Dhabi, United Arab Emirates; from PCR to antibody. BMC Nephrol. 2020;22,198. DOI: 10.1186/s12882-021-02378-y

  7. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395(10226):809-15. DOI: 10.1016/S0140-6736(20)30360-3

  8. Chen N, Zhou M, Dong X. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13. DOI: 10.1016/S0140-6736(20)30211-7

  9. Shailesh-Kumar P, Singha R, Ranab J, Tiwaric R, Natesand S, Harapane H, et al. The kidney and COVID-19 patients. Important considerations. Travel Medicine and Infectious Disease. 2020;37:101831. DOI: 10.1016/j.tmaid.2020.101831

  10. Cárdenes-León A, Hernández-Meneses B, Sánchez-Pérez A, Novoa-Medina Jm, Bujanda-MorúnPF, Martín-Lorenzo P. Síndrome coronario agudo y shock en el contexto de infección aguda por COVID-19. Rev Esp Cardiol. 2020;73(8):665-87. DOI: 10.1016/j.recesp.2020.05.005

  11. Chen Y, Luo R, Wang K. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97:829-38. DOI: 10.1016/j.kint.2020.03.005

  12. Zhen Li, Ming Wu, Jie Guo. Caution on Kidney Dysfunctions of 2019-nCoV Patients. MedRxiv. Preprints. 2020. DOI: 10.1101/2020.02.08.20021212

  13. Xu D, Zhang H, Gong H, Chen J, Ye J, Meng T, et al. Identification of a Potential Mechanism of Acute Kidney Injury During the Covid-19 Outbreak: A Study Based on Single-Cell Transcriptome Analysis. Intensive care Med. 2020;46(6):1114-1116. DOI: 10.1007/s00134-020-06026-1

  14. Ikizler T. COVID-19 y Unidades de Diálisis: ¿Qué sabemos ahora y qué debemos hacer? AJKD. 2020;76(1):1-3 DOI: 10.1053/j.ajkd.2020.03.008

  15. Yichun Cheng, Ran Luo, Kun Wang, Meng Zhang, Zhixiang Wang, Lei Don, et al. La enfermedad renal está asociada con muerte hospitalaria de pacientes con COVID-19. Kidney International. 2020;97:829-38. DOI: 10.1016/j.kint.2020.03.005

  16. Hua S, Ming Y, Chen W, Li-Xia Y, Fang T, Hong-Yan Z, et al. Análisis histopatológico renal de 26 hallazgos postmortem de pacientes con COVID-19 en China. Kidney International. 2020;88(1):219-227. DOI: 10.1016/j.kint.2020.04.003

  17. Mihalopoulos M, Dogra N, Mohamed N, Badani K, Kyprianou N. COVID-19 and Kidney disease: molecular determinants and clinical implications in renal cancer. Eur Urol Focus. 202;6(5):1086-1096. DOI: 10.1016/j.euf.2020.06.002

  18. Pallarés-Carratalá V, Górriz-Zambrano C, Morillas-Ariño C, Llisterri-Caro JC, Gorriz JL. COVID-19 y enfermedad cardiovascular y renal: ¿Dónde estamos? ¿Hacia dónde vamos? Semergen. 2020;46(1):78-87. DOI: 10.1016/j.semerg.2020.05.005

  19. Shetty AK. Mesenchymal Stem Cell Infusion Shows Promise for Combating Coronavirus (COVID-19) Induced Pneumonia. Aging and Disease. 2020;11(2):462-4. DOI: 10.14336/AD.2020.0301

  20. Diao B, Feng Z, Wang C. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2). Infection. 2020;12(1):2506. DOI: 10.1101/2020.03.04.20031120v2

  21. McMichael TM, Currie DW, Clark S, Pogosjans S, Kay M, Schwartz NG, et al. Epidemiology of COVID-19 in a long-term care facility in King County, Washington. N Engl J Med. 2020;382:2005-11. DOI: 10.1056/NEJMoa2005412

  22. Perico L, Benigni A, Remuzzi G. Should COVID-19 Concern Nephrologists?Why and to What Extent? The Emerging Impasse of Angiotensin Blockade. Nephron. 2020;144(5):213-221. DOI: 10.1159/000507305

  23. Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet. 2020;395:1225-28. DOI:10.1016/S0140-6736(20)30627-9

  24. Ronco C, ThiagReis T. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nature reviews. 2020;16(6):308-310. DOI: 10.1038/s41581-020-0284-7

  25. Wang L, Li X, Chen H, Yan S, Li D, Li Y,et al. Coronavirus Disease 19 Infection Does Not Result in Acute Kidney Injury: An Analysis of 116 Hospitalized Patients from Wuhan, China. Am J Nephrol. 2020;51(5):343-348. DOI: 10.1159/000507471

  26. Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. International Urology and Nephrology. 2020;52(6):1193-1194. DOI: 10.1007/s11255-020-02451-9

  27. Mubarak M, Nasri H. COVID-19 nephropathy; an emerging condition caused by novel coronavirus infection. J Nephropathol. 2020;9(3):e21. DOI: 10.34172/jnp.2020.21




2020     |     www.medigraphic.com